Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2026)
Neurogene (NGNE) reported Other Non-Current Liabilities of $407,000 for Q2 2026, down 44.9% from $738,000 a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene posted Other Non-Current Liabilities of $428,000, down 40.4% from FY2024.
- By year, Other Non-Current Liabilities came in at $718,000 in FY2024 (-28.6%) and $1.01 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q2 2019.
- Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with an average decline of 29.0% over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $409,000 (Q1 2026), $428,000 (Q4 2025) and $427,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Neurogene | 577.56 Mn | -425.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 407,000.00 |
| Mar 31, 2026 | 409,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Jun 30, 2025 | 789,000.00 |
| Mar 31, 2025 | 789,000.00 |
| Dec 31, 2024 | 769,000.00 |
| Sep 30, 2024 | 697,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 313,000.00 |
| Sep 30, 2018 | 343,000.00 |
| Jun 30, 2018 | 401,000.00 |
| Mar 31, 2018 | 443,000.00 |
| Dec 31, 2017 | 486,000.00 |
| Sep 30, 2017 | 513,000.00 |
| Jun 30, 2017 | 548,000.00 |
API Access
Neurogene Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();